Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 7601 - 7625 of 7757 in total

2-(2-hydroxy-phenyl)-3H-benzoimidazole-5-carboxamidine

Experimental

N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]naphthalene-2-carbohydrazide

Experimental

2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol

Experimental

Talinolol

Talinolol has been investigated for the basic science of Gastrointestinal Motility Disorder.
Investigational

Desaspidin

Experimental

CRA_10655

Experimental

N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide

Experimental

N'-[(1E)-(3,5-DIBROMO-2,4-DIHYDROXYPHENYL)METHYLENE]NICOTINOHYDRAZIDE

Experimental

Carbazochrome

Carbazochrome is a hemostatic agent that promotes clotting, preventing blood loss from open wounds. It is an oxidation product of adrenaline which enhances the microcirculatory tone . In the future this may prevent excessive blood flow during surgical operations and the treatment of hemorrhoids, but research on effectiveness and severity...
Experimental
Withdrawn

Triciribine

Triciribine has been used in trials studying the treatment of Leukemia, Ovarian Cancer, HER2/Neu Negative, Breast Adenocarcinoma, and Stage IV Breast Cancer, among others.
Investigational

Tioclomarol

Experimental

Iprazochrome

Experimental

CRA_1144

Experimental

(5E)-2-Amino-5-(2-pyridinylmethylene)-1,3-thiazol-4(5H)-one

Experimental

Albendazole oxide

Experimental

2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine

Experimental

(2Z)-1-(5-Chloro-1H-indol-3-yl)-3-hydroxy-3-(1H-tetrazol-5-yl)-2-propen-1-one

Experimental

3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol

Experimental

Apigenin

Experimental

N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA

Experimental

4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM

Experimental

1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL

Experimental

Ranimustine

Experimental

GO-203-2C

GO-203-2C is under investigation in clinical trial NCT02204085 (A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia).
Investigational
Matched Iupac: … hydroxypentylidene]amino}-1-hydroxypentylidene]amino}-1-hydroxyhexylidene]amino}-3-(C-hydroxycarbonimidoyl)propanoic acid …

A-98881

Experimental
Displaying drugs 7601 - 7625 of 7757 in total